Is Journey Medical Corp halal to invest in?

As of July 2026, Journey Medical Corp DERM is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is Journey Medical Corp a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Journey Medical Corp using these criteria to determine its compliance status.

Can Muslims buy shares of Journey Medical Corp?

Muslim investors may consider investing in Journey Medical Corp if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Journey Medical Corp classified as HALAL?

Musaffa determines the Shariah status of Journey Medical Corp by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Journey Medical Corp updated?

The Shariah compliance status of Journey Medical Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Journey Medical Corp become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Journey Medical Corp?

You can check the latest Shariah compliance status of Journey Medical Corp on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

DERM Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, Journey Medical Corp is classified as halal.

HALAL

Report Source: 2026 1st Quarter Report

Journey Medical Corp. Stock Analysis DERM

United States Health Care Micro Cap Report: Q1, 2026

Journey Medical Corp. is a commercial-stage pharmaceutical company, which focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company is headquartered in Scottsdale, Arizona and currently employs 58 full-time employees. The company went IPO on 2021-11-12. The firm is focused on selling and marketing of the United States Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the United States. Its marketed products, which have been approved FDA for sale in the United States, include Qbrexza, Accutane, Amzeeq, Zilxi, Exelderm Cream and Solution, Targadox, and Luxamend. Qbrexza is a medicated cloth towelette for the treatment of primary axillary hyperhidrosis. Accutane is an oral isotretinoin drug for the treatment of severe recalcitrant nodular acne. Targadox is an oral doxycycline drug for adjunctive therapy for severe acne. Luxamend is a water-based emulsion formulated to provide moist healing environment.

Key Statistics of Journey Medical Corp (DERM)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$6.58$7.14

Today's Open

$7.11

Volume

116.86K

P/E Ratio (TTM)

52 Week Range

$4.31$9.56

Market Cap

183.93M

Avg. Volume

309.74K

Dividend Yield

Financial Metrics & Statements of Journey Medical Corp (DERM)

Super Investors Invested in Journey Medical Corp (DERM)

FAQ's for Journey Medical Corp (DERM)

As of July 2026, Journey Medical Corp DERM is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Journey Medical Corp using these criteria to determine its compliance status.
Muslim investors may consider investing in Journey Medical Corp if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of Journey Medical Corp by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of Journey Medical Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of Journey Medical Corp on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.